Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Fraenkel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Endocrine Regulations|May 15, 2023
IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patientsEmil Fraenkel, Ivica Lazurova
Orvosi Hetilap|May 4, 2004
[Role of lipid peroxidation in non-alcoholic steatohepatitis]Emil Fraenkel, Ivica Lazúrová, János Fehér
Orvosi Hetilap|November 2, 2005
[Hepatorenal syndrome]Péter Jarcuska, Emil Fraenkel, János Fehér
Minerva Endocrinology|July 25, 2025
Associations between DXA-derived parameters of body composition and metabolic dysfunction-associated steatotic liver disease in patients with T2DM and prediabetic statesEmil Fraenkel, Tomáš Koky, Samuel Štellmach, et al.
BMC Endocrine Disorders|April 6, 2026
Associations between DXA-derived parameters of body composition and bone mass density in patients with T2DM and metabolic dysfunction-associated steatotic liver disease: a cross-sectional studyEmil Fraenkel, Martin Kaško, Tomáš Koky, et al.
The Journal of International Medical Research|June 21, 2023
Concomitant occurrence of Wernicke's encephalopathy and sarcopenia due to vitamin D depletion in patients with alcohol use disorder: a case reportEmil Fraenkel, Michal Orlický, Miriam Fedičová, et al.
Orvosi Hetilap|April 25, 2007
[Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]Emil Fraenkel, Rita Takács, József Hamvas, et al.
Orvosi Hetilap|July 21, 2009
[Does carbohydrate-deficient transferrin have diagnostic value in non-alcoholic fatty liver disease?]Emil Fraenkel, György Szabó, Gabriella Lengyel, et al.
International Journal of Molecular Sciences|August 12, 2022
Theories and Molecular Basis of Vascular Aging: A Review of the Literature from VascAgeNet Group on Pathophysiological Mechanisms of Vascular AgingEugenia Gkaliagkousi, Antonios Lazaridis, Soner Dogan, et al.
Orvosi Hetilap|March 21, 2012
[Carbohydrate-deficient transferrin in doping and non-doping athletes]György Szabó, Emil Fraenkel, Gergely Szabó, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Endocrine Regulations|May 15, 2023
IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patientsEmil Fraenkel, Ivica Lazurova
Orvosi Hetilap|May 4, 2004
[Role of lipid peroxidation in non-alcoholic steatohepatitis]Emil Fraenkel, Ivica Lazúrová, János Fehér
Orvosi Hetilap|November 2, 2005
[Hepatorenal syndrome]Péter Jarcuska, Emil Fraenkel, János Fehér
Minerva Endocrinology|July 25, 2025
Associations between DXA-derived parameters of body composition and metabolic dysfunction-associated steatotic liver disease in patients with T2DM and prediabetic statesEmil Fraenkel, Tomáš Koky, Samuel Štellmach, et al.
BMC Endocrine Disorders|April 6, 2026
Associations between DXA-derived parameters of body composition and bone mass density in patients with T2DM and metabolic dysfunction-associated steatotic liver disease: a cross-sectional studyEmil Fraenkel, Martin Kaško, Tomáš Koky, et al.
The Journal of International Medical Research|June 21, 2023
Concomitant occurrence of Wernicke's encephalopathy and sarcopenia due to vitamin D depletion in patients with alcohol use disorder: a case reportEmil Fraenkel, Michal Orlický, Miriam Fedičová, et al.
Orvosi Hetilap|April 25, 2007
[Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]Emil Fraenkel, Rita Takács, József Hamvas, et al.
Orvosi Hetilap|July 21, 2009
[Does carbohydrate-deficient transferrin have diagnostic value in non-alcoholic fatty liver disease?]Emil Fraenkel, György Szabó, Gabriella Lengyel, et al.
International Journal of Molecular Sciences|August 12, 2022
Theories and Molecular Basis of Vascular Aging: A Review of the Literature from VascAgeNet Group on Pathophysiological Mechanisms of Vascular AgingEugenia Gkaliagkousi, Antonios Lazaridis, Soner Dogan, et al.
Orvosi Hetilap|March 21, 2012
[Carbohydrate-deficient transferrin in doping and non-doping athletes]György Szabó, Emil Fraenkel, Gergely Szabó, et al.
Pageof 2